ストックスクリーナーアプリを入手
2.869
130.00%
1.619
前日終値:
$1.25
開ける：
$1.89
24時間の取引高:
371.90M
Relative Volume:
58.01
時価総額：
$9.35M
収益：
$960.60K
当期純損益:
$-7.10M
株価収益率:
-0.3795
EPS:
-7.56
ネットキャッシュフロー:
$-8.00M
1週間 パフォーマンス:
+106.83%
1か月 パフォーマンス:
+119.47%
6か月 パフォーマンス:
+23.39%
1年 パフォーマンス:
-31.71%
1日の値動き範囲:
$1.66
$5.38
1週間の範囲:
$1.18
$5.38
52週間の値動き範囲:
$1.09
$5.40
Soligenix Inc Stock (SNGX) Company Profile
SNGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SNGX
Soligenix Inc
|
2.865 | 4.15M | 960.60K | -7.10M | -8.00M | -7.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.09 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
543.63 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.17 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
668.73 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.25 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Soligenix Inc Stock (SNGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-07-28 | ダウングレード | Dawson James | Buy → Neutral |
| 2018-01-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2017-08-14 | 繰り返されました | Maxim Group | Buy |
| 2017-07-17 | 開始されました | H.C. Wainwright | Buy |
Soligenix Inc (SNGX) 最新ニュース
Soligenix’s Phase 3 Study on HyBryte for CTCL: Key Insights for Investors - TipRanks
What markets is FATBB expanding into Is Soligenix Inc. stock a good long term investment optionWealth Building Planner With Proven Results - jammulinksnews.com
Soligenix shares surge 106.40% intraday after completing Phase 2a proof of concept study for SGX945 in Behcet's Disease. - AInvest
Soligenix Stock Soars: Is A Rebound Imminent? - StocksToTrade
Why Is Soligenix Stock (SNGX) Up 50% Today? - TipRanks
Is Soligenix Inc. a growth stock or a value stockTop Growth Ideas For 2025 - jammulinksnews.com
Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial - Yahoo Finance
Soligenix reports positive results from SGX945 Behçet’s trial - Investing.com
Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet's Disease - PR Newswire
What institutional investors are buying Soligenix Inc. stockExpert Picks Outlook From AI Tools - jammulinksnews.com
Long term hold vs stop loss in Soligenix Inc.AI Powered Stock Trend Prediction Model - Newser
What momentum shifts mean for Soligenix Inc.Trade Safety Report with Pattern Insights - Newser
Can technical indicators confirm Soligenix Inc.’s reversalTechnical Confirmation System with Signal Alerts - Newser
What institutional flow reveals about Soligenix Inc.Long-Term Trend Tracking and Signal Summary - Newser
Why Soligenix Inc. stock attracts strong analyst attentionMulti-Year Investment Performance Summary Report - Newser
Multi factor analysis applied to Soligenix Inc.ROI Focused Watchlist with Trade Confidence - Newser
What makes Soligenix Inc. stock price move sharplyHistorical Stock Summary and ROI Review - Newser
Soligenix Inc. Stock Support and Resistance Levels You Should KnowAI Based High Gain Watchlist Scanner Shared - metal.it
Real time social sentiment graph for Soligenix Inc.High Yield Watchlist with Filtered Picks - Newser
Order Flow Trends Show Accumulation in Soligenix Inc.Weekly Stock Opportunity Radar Scanner Activated - metal.it
How did Soligenix's revenue and expenses trend in Q4 2024? - AInvest
Published on: 2025-07-29 03:42:31 - metal.it
Why is Soligenix Inc. stock attracting strong analyst attentionDaily Trading Signals That Work - jammulinksnews.com
What is the dividend policy of Soligenix Inc. stockCapitalize on market momentum for profits - jammulinksnews.com
What is Soligenix Inc. company’s growth strategyAchieve breakthrough investment performance - jammulinksnews.com
How volatile is Soligenix Inc. stock compared to the marketTake advantage of unprecedented market momentum - jammulinksnews.com
What is the risk reward ratio of investing in Soligenix Inc. stockIdentify safe investments with exceptional yields - jammulinksnews.com
Top Risks to Consider Before Buying Soligenix Inc. StockStable Stocks With High Yield - Newser
What catalysts could drive Soligenix Inc. stock higher in 2025Capitalize on market trends with confidence - jammulinksnews.com
How Soligenix Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
Soligenix Inc. Advances Treatment for Behçet’s Disease with SGX945 - citybuzz -
What analysts say about Soligenix Inc. stockSky-high return potential - PrintWeekIndia
Soligenix Inc. Stock Analysis and ForecastFree Capital Allocation Plans - PrintWeekIndia
Soligenix (NASDAQ: SNGX) Pioneering Oral Mucositis Treatment with Novel Therapeutic - The Globe and Mail
Soligenix (NASDAQ: SNGX) Pioneering Oral Mucositis Treatment With Novel Therapeutic - Barchart.com
How Soligenix Inc. stock reacts to Fed policy changesPhenomenal wealth increase - jammulinksnews.com
Is Soligenix Inc. stock a good hedge against inflationAccelerated capital growth - jammulinksnews.com
Soligenix Inc (SNGX) 財務データ
収益
当期純利益
現金流量
EPS
4.06%
1.77%
大文字化:
|
ボリューム (24 時間):